We just posted a chart showing the market cap of Algernon Pharmaceuticals (CSE: AGN). Back on December 14, 2020, AGN closed with a market cap of $68 million.
AGN's current market cap including the newly issued shares from this week's private placement is only $11.51 million.
AGN would need to increase 5.907X higher in share price to $28.89 per share to return to its market cap from December 14, 2020.
AGN's biggest catalyst in history is ahead with its Phase 1 trial of DMT for stroke beginning in the 4Q of this year!
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from AGN of US$100,000 cash for a twelve-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.
Preparing Americans for Hyperinflation
